PRECISION MEDICINE AND THERAPEUTIC GENE EDITING Flashcards
What is the difference between precision medicine and personalised medicine?
- Precision medicine is using MEDICAL INTERVENTIONS to alter molecular mechanisms that cause disease or INFLUENCE a patients response to certain treatments
- Personalised medicine is working out which medical treatments work best for each patient.
What is Moore’s law?
- Long term trend in computer hardware that involves the doubling of computer power every 2 years
What is the general term for Anti Sense Olgio nucleotides?
- Small pieces of DNA that change the way DNA is expressed
- Can be shortened to ASO
Does it matter if introns are correctly or incorrectly splieced?
- YES because we need to get the right reading frame
- IF not correctly spliced, can lead to non-functional proteins
What is a phase 0 intron?
- When there is NO CODON shared between exons after splicing
What is a phase 1 and 2 intron?
- When after splicing out of introns, there is a codon shared between two exons, e.g. C and G
- phase 2 intron where there are 2 nucleotides on the first exon that are spliced with 1 nucleotide on the third intron to make one codon
What can happen if exons are incorrectly spliced together?
- proteins can be our of reading frame and thus non functional
What is an approach used to work around non-functional (out of reading frame) proteins?
- Therapeutic approaches using antisense oligonucleotides (ASOs)
What is the specific definition of antisense oligonucleotides. ( ASOs)?
- Short single stranded sequence of DNA or RNA designed to target specific RNAs to modify gene expression.
What are three ways that ASOs exert their effects and what does this depend on?
- RNA degradation.
- preventing protein translocation.
- modifying RNA splicing.
What are two diseases that ASOs are used to treat?
- Spinal Muscular Atrophy
2. DMD (Duchennes Muscular Dystrohpy)
What is SMA caused by and characterised by?
Loss-of-function mutations in SINGLE gene –>SMN1 (Survival Motor Neuron 1)
- Characterized by progressive degeneration of the spinal cord motor neurons.
Is there a second SMN gene and how much of the normal protein is produced?
Yes SMN2
- But only 10-20% of the normal protein is produced
How do the SMN1 and SMN2 genes differ in terms of the strucutre?
- Differ in 5 bases
- C–> T transition in exon 7 means that SMN2 favors SKIPPING of exon 7 during splicing
- This means that majority of SMN2 products are UNSTABLE and thus truncated –> SMN delta7
Can SMA patients with no SMN1 still produce a functional SMN protein at sufficient levels for function?
- NO –> levels are insufficient for normal function so this results in degeneration of the spinal cord motor neurons
How can ASOs be used to treat SMA (Spinal Muscular Atrophy)?
- Can try and shift the machinery so it recognises exon 7
How is the drug ‘Spiranza’ used to treat SMA?
- Shifting machinery to recognise exon 7
- Blocking the 15 nucleotide sequence in intron 7 SMN2 (this is crucial for splicing regulation) –> ISS-N1 (intronic splicing silencer N1)
- ISS-N1 blocking ASOs lead to the production of exon 7 and INCREASED EXPRESSION of SMN2
What is the target for Spiranza to allow for a fix of SMA?
- ISS-N1
- This is the intronic splicing silencer N1 that is imprtant in splicing regulation
- If it is blocked, then exon 7 will be recognised and integrated to produce a full length SMA2
What is dystrophin?
- Parts of a protein complex and anchors the cytoskeleton in muscle cell with the ECM (linker between Actin and ECM).
What happens if we don’t have dystrophin?
The muscles degrade.